Antidote Treatment Nerve Agent Auto-Injector (ATNAA)
SOL #: SPE2DP-26-D-0001Justification
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Philadelphia, PA
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Dec 10, 2025
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
In accordance with FAR 6.305(a), please see attachment for the redacted justification and approval for contract award to Meridian Medical Technologies, LLC for the manufacture and delivery of ATNAA.
People
Points of Contact
Jessica De La HozPRIMARY
Files
Files
Versions
Version 1Viewing
Justification
Posted: Dec 10, 2025